Cell-permeable iron inhibits vascular endothelial growth factor receptor-2 signaling and tumor angiogenesis

Por Kir, Devika, Saluja, Manju, Modi, Shrey, Venkatachalam, Annapoorna, Schnettler, Erica, Roy, Sabita, Ramakrishnan, Sundaram
Publicado no Oncotarget (2016)

Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug()

Por Rivard, Colleen, Geller, Melissa, Schnettler, Erica, Saluja, Manju, Vogel, Rachel Isaksson, Saluja, Ashok, Ramakrishnan, Sundaram
Publicado no Gynecol Oncol (2014)

Feasibility of Integrating Panel-Based Pharmacogenomics Testing for Chemotherapy and Supportive Care in Patients With Colorectal Cancer

Por Kasi, Pashtoon Murtaza, Koep, Tyler, Schnettler, Erica, Shahjehan, Faisal, Kamatham, Vaishnavi, Baldeo, Candice, Hughes, Caren L.
Publicado no Technol Cancer Res Treat (2019)

5,6-Dihydro-5-aza-2’-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors

Por Rawson, Jonathan M., Heineman, Richard H., Beach, Lauren B., Martin, Jessica L., Schnettler, Erica K., Dapp, Michael J., Patterson, Steven E., Mansky, Louis M.
Publicado em 2013

Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis

Por Joshi, Hemant P., Subramanian, Indira V., Schnettler, Erica K., Ghosh, Goutam, Rupaimoole, Rajesha, Evans, Colleen, Saluja, Manju, Jing, Yawu, Cristina, Ivan, Roy, Sabita, Zeng, Yan, Shah, Vijay H., Sood, Anil K., Ramakrishnan, Sundaram
Publicado em 2014